explore -WSS

explore

author：hotspot 2025-09-27 13:09:38 - browse：72167

accountable care organizations cost saving — Adobe

WASHINGTON — A key Obama-era initiative was supposed to save Medicare money by testing new policies for cutting health care costs. It has so far failed to do so, according to nonpartisan congressional budget experts, and it’s not expected to save money anytime soon.

The 2010 Affordable Care Act created a government center, named the Center for Medicare and Medicaid Innovation, that was given $10 billion over a decade to test new Medicare and Medicaid pay policies. It has since been funded at the same level for another 10 years.

Republicans have attacked the center over the years. Although most of its pilot programs involve lowering hospital spending, some of the center’s initiatives aiming to lower spending on drugs have often provoked GOP ire. Most recently, they attacked the center’s proposal to cut Medicare pay for drugs that receive accelerated approvals. The Trump administration also used pilot programs to cut drug spending, including its failed attempt to tie Medicare drug payments to prices abroad.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Christmas in the PICU brings some surprising joy

knowledge

hotspot

WSS

SEC charges former device maker CEO with $41 million fraud

Results on Novartis prostate cancer therapy could expand its use

FDA clears Verve to begin U.S. study of gene

Roivant's CEO is a star, but biotech's black hole persists

Medicare Advantage beneficiaries sue Humana over algorithm use

Violet CEO on training clinicians to promote more inclusive care

focus

explore

Wikipedia

Medical records are filled with copy

Health tech investors get more selective as pandemic boom fades

Medical records are filled with copy

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Medicare proposal to cover medical devices draws a mixed reaction

HCA sued by state AG for quality issues at Mission Health

How one medical school became remarkably diverse

David Ricks of Eli Lilly: best biopharma CEO of 2023

The cancer drug shortage isn’t new — and neither are the solutions

HCA sued by state AG for quality issues at Mission Health

leisure time

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Grail spinoff by Illumina should end disastrous merger attempt

Prime Medicine, Myeloid Therapeutics clash over genome